Patent granted for Dendritic Nanogel carriers (DNG) in the US
Polymer Factory Sweden AB (publ) announces that the patent application for the Company’s dendritic nanogel platform (DNG) has been granted and issued as of 2nd July 2024, by the US Patent and Trademark Office, USPTO.
The DNG platform is an innovative nanocarrier platform based on dendritic materials, with the potential to encapsulate, transport, and control the release of cargo (e.g., pharmaceuticals, peptides, and antibiotics). DNG is Polymer Factory’s alternative carrier to already established liposome carriers.
CEO Elin Mignérus:
"A strong patent protection is valuable both for Polymer Factory and for potential future partners. Our main commercial focus is on Europe and the USA, why this decision from the USPTO is an important step forward in our journey to commercialize the DNG platform"
The filing date for the patent application is August 13, 2019, and it is granted for 20 years from the validity date, which provides market exclusivity during this period. Polymer Factory has filed corresponding patent applications in other geographies.
For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.